Literature DB >> 33505811

Impact of Quarantine During COVID-19 Pandemic on the Quality of Life of Patients with Allergic Conjunctivitis.

Walaa Al-Dairi1, Ali A Al Saeed2, Omar M Al Sowayigh2.   

Abstract

Introduction The conjunctiva is one of the most frequently damaged targets for inflammatory responses induced by allergic immunological hypersensitivity reactions. Allergic conjunctivitis (AC) typically manifests as a spectrum of potential severity, ranging from mild symptoms to severe troublesome symptoms that might interfere significantly with daily activities and overall quality of life. Aim This study aimed to evaluate impact of the quarantine during the COVID-19 pandemic on the quality of life of allergic conjunctivitis patients. Methodology  This is a cross-sectional study conducted among confirmed patients with allergic conjunctivitis in Saudi Arabia from the period of July 2020 to September 2020. An electronic validated structured-questionnaire explored the participants' demography, symptoms, known allergen and risk factors, and patient psychological and functional domains of life using Eye Allergy Patient Impact Questionnaire (EAPIQ). Data were gathered in MS Excel and all statistical analyses were performed using SPSS version 21. Results The most common symptoms of AC was itching (79.9%) and redness of the eye (38.8%), while the most common causes was dust (46.9%) and pollens (46.9%). With regards to the assessment of EAPIQ, the mean score was higher in the impact of eye allergy symptoms domain (mean 12.6 ± 4.84 SD.), while it was lower in the impact of AC on the psychological and emotional domain (mean 10.7 ± 5.62 SD.). Statistical analysis revealed that previous history of AC and a visit to healthcare provider were the significant factors associated with the increased risk of eye allergy symptoms, troubled daily activities and bothered psychological and emotional life. Conclusion This study demonstrated that a patients' eye allergy symptoms affect many aspects of patients' daily activities. In addition to affecting functionality, these symptoms also affect patients' emotional state. Although the impact of daily activities and emotions due to eye allergy were minimal, the impact of eye allergy symptoms during quarantine period was still found to be moderate. We found the severity of AC & its impact over a patients' quality of life was moderate which suggests there was no major effect found on AC severity during the COVID-19 pandemic quarantine period. Further studies with detailed analysis of triggering factors might lead to a better understanding of the disease and its relation to the patients' activities & lifestyle which can directly affect the AC management & quality of life.
Copyright © 2020, Al-Dairi et al.

Entities:  

Keywords:  allergic conjunctivitis; covid-19; ocular allergy; preventive ophthalmology; quarantine

Year:  2020        PMID: 33505811      PMCID: PMC7822578          DOI: 10.7759/cureus.12240

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

1.  The epidemiology of ocular and nasal allergy in the United States, 1988-1994.

Authors:  Kavita Singh; Sara Axelrod; Leonard Bielory
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

Review 2.  Outdoor air pollution and asthma.

Authors:  Michael Guarnieri; John R Balmes
Journal:  Lancet       Date:  2014-05-03       Impact factor: 79.321

Review 3.  Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients.

Authors:  Eli O Meltzer; Judith Rosen Farrar; Cary Sennett
Journal:  J Allergy Clin Immunol Pract       Date:  2016-11-30

4.  Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue.

Authors:  P Isaacson; D H Wright
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

5.  Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study.

Authors:  Giuseppe Verlato; Angelo Corsico; Simona Villani; Isa Cerveri; Enrica Migliore; Simone Accordini; Adriana Carolei; Pavilio Piccioni; Massimiliano Bugiani; Vincenzo Lo Cascio; Alessandra Marinoni; Albino Poli; Roberto de Marco
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

6.  Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life.

Authors:  Jorge Palmares; Luis Delgado; Manuela Cidade; Maria J Quadrado; Helena P Filipe
Journal:  Eur J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 2.597

7.  The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).

Authors:  Michael Alexander; William Berger; Patricia Buchholz; John Walt; Caroline Burk; Jeff Lee; Rob Arbuckle; Linda Abetz
Journal:  Health Qual Life Outcomes       Date:  2005-10-31       Impact factor: 3.186

8.  Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic.

Authors:  Amiel A Dror; Netanel Eisenbach; Tal Marshak; Eli Layous; Asaf Zigron; Shaked Shivatzki; Nicole G Morozov; Shahar Taiber; Eran E Alon; Ohad Ronen; Eyal Zusman; Samer Srouji; Eyal Sela
Journal:  J Allergy Clin Immunol Pract       Date:  2020-09-02

9.  Air pollution significantly associated with severe ocular allergic inflammatory diseases.

Authors:  Dai Miyazaki; Kazumi Fukagawa; Atsuki Fukushima; Hiroshi Fujishima; Eiichi Uchio; Nobuyuki Ebihara; Jun Shoji; Etsuko Takamura; Kenichi Namba; Yuichi Ohashi; Shigeki Okamoto; Yoshiyuki Satake; Hiroshi Ohtsu; Yumiko Shimizu; Yoshitsugu Inoue
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

10.  Effect of restricted emissions during COVID-19 on air quality in India.

Authors:  Shubham Sharma; Mengyuan Zhang; Jingsi Gao; Hongliang Zhang; Sri Harsha Kota
Journal:  Sci Total Environ       Date:  2020-04-22       Impact factor: 7.963

View more
  3 in total

1.  Impact of screen exposure on pediatric vernal Keratoconjunctivitis: a survey during the COVID-19 pandemic in Italy.

Authors:  Marzio Masini; Giulia Brindisi; Roberto Caputo; Anna Maria Zicari; Mattia Giovannini; Elia Pignataro; Laura Di Grande; Cinzia De Libero; Marcella Nebbioso; Francesca Mori
Journal:  Ital J Pediatr       Date:  2022-05-14       Impact factor: 3.288

Review 2.  Ocular manifestations of COVID-19.

Authors:  Mashael Al-Namaeh
Journal:  Ther Adv Ophthalmol       Date:  2022-04-12

3.  Sustained Reductions in Online Search Interest for Communicable Eye and Other Conditions During the COVID-19 Pandemic: Infodemiology Study.

Authors:  Michael S Deiner; Gerami D Seitzman; Gurbani Kaur; Stephen D McLeod; James Chodosh; Thomas M Lietman; Travis C Porco
Journal:  JMIR Infodemiology       Date:  2022-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.